logo
16:01 Dec 05

Jenburkt Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1099.95
-5.75 (-0.52%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. Financials

Jenburkt Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1099.95
-5.75 (-0.52%)
16:01 Dec 05
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

38/100
Technically Neutral

Strength

9

Weakness

4

Opportunity

0

Threats

0

18.66 %

ROE %

16.34 %

ROA %

0.00

EPS

389.22

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
123.98 136.75 141.97 151.69 159.03
Operating Expenses +
96.73 106.38 108.85 111.3 117.26
Raw Material
33.72 31.67 30.8 29.77 30.68
Increase Decrease in Cost
-2.28 1.34 -0.39 -0.12 -0.73
Other Manufacturing Expense
0.63 0.8 0.73 1.16 0
Employee Cost
36.49 38.81 42.49 45.54 48
Miscellaneous Expenses
72.13 74.86 80.04 77.47 39.31
Operating Profit
27.25 30.37 33.12 40.39 41.77
Other Income
4.95 5.12 4.67 6.72 7.6
Depreciation
1.9 2.26 2.34 2.73 3.03
Interest
0.43 0.37 0.27 0.45 0.44
Profit before tax and exceptio..
29.87 32.86 35.18 43.93 45.9
Exceptional Items
0 0 0 0 0
PBT
29.87 32.86 35.18 43.93 45.9
Provision for Taxation
7.57 8.26 9.2 11.87 12.87
Net Profit
22.3 24.61 25.98 32.06 33
NET Profit after MI
0 0 0 0 0
EPS
48.58 53.9 58.86 72.65 74.78
Operating Profit Margin (%)
21.98 22.21 23.33 26.63 26.27
Net Profit Margin (%)
17.99 18 18.3 21.14 20.75

Jenburkt Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 46.70 46.70 46.70 46.70 46.70 46.70
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.10 0.10 0.10 0.10 0.00 0.00
Others 53.20 53.20 53.20 53.20 53.30 53.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: